Grant: Operating Grant - PA: HIV/AIDS - Comorbidity - Biomedical/Clinical Research
University of British Columbia
$374,683.00
Emphysema and inflamm-aging in HIV-seropositive patients
FY 2011-12
Summary
Chronic obstructive lung disease affects ~10% of adult Canadians and is the 4th leading cause of death, and the 3rd leading cost of health care expenses. In susceptible individuals, premature aging of the lung can be triggered by exposure of noxious materials, such as cigarette smoking, environmental pollution, and infection. Surprisingly, this condition will continue to progress even after the noxious exposure has ceased years ago.
The widespread use of highly effective treatment for HIV infection has improved the survival of these patients from 10-2 to 1-3 per 100 person years. These individuals are dying frequently of coronary artery disease, malignancies, and emphysema, but two decades earlier than in the general population.
A disease such as emphysema that takes decades to evolve gives physicians time to intervene, but it also makes it difficult to decide what we do has made a difference until years/decades later. For a variety of reasons, HIV infection has put emphysema on a fast track, allowing the disease and its complications to develop in years instead of decades.
There are several benefits of the proposed study to Canadians. By finding out the reason why emphysema is so common and why it occurs at a younger in HIV patients will enable the health care professionals and officials come up with a better strategy to manage the problem with public health measures, pharmacological and non-pharmacological treatment. Because of the aggressive nature of the condition, we will be able find out if the treatment would work over a shorter time course (months or years instead of decades). We will also gain important insight into the aging process, such as how a viral infection and emphysema may contribute to premature aging, and vice versa. Finally, this study may identify individuals who are at risk of developing emphysema with simple blood tests and lung function, so that a concerted effort can be directed to those who will be most likely in need of help.
Department
Program
Operating Grant - PA: HIV/AIDS - Comorbidity - Biomedical/Clinical Research
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
246982
Name
Man S.F. Paul
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Respiratory System
Projecttitle
Emphysema and inflamm-aging in HIV-seropositive patients
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$374,683
Cihrequipment2
$0
Programname2
Operating Grant - PA: HIV/AIDS - Comorbidity - Biomedical/Clinical Research
Keyworddelim
Aging; Emphysema; Hiv; Inflammation
Abstract
Chronic obstructive lung disease affects ~10% of adult Canadians and is the 4th leading cause of death, and the 3rd leading cost of health care expenses. In susceptible individuals, premature aging of the lung can be triggered by exposure of noxious materials, such as cigarette smoking, environmental pollution, and infection. Surprisingly, this condition will continue to progress even after the noxious exposure has ceased years ago.
The widespread use of highly effective treatment for HIV infection has improved the survival of these patients from 10-2 to 1-3 per 100 person years. These individuals are dying frequently of coronary artery disease, malignancies, and emphysema, but two decades earlier than in the general population.
A disease such as emphysema that takes decades to evolve gives physicians time to intervene, but it also makes it difficult to decide what we do has made a difference until years/decades later. For a variety of reasons, HIV infection has put emphysema on a fast track, allowing the disease and its complications to develop in years instead of decades.
There are several benefits of the proposed study to Canadians. By finding out the reason why emphysema is so common and why it occurs at a younger in HIV patients will enable the health care professionals and officials come up with a better strategy to manage the problem with public health measures, pharmacological and non-pharmacological treatment. Because of the aggressive nature of the condition, we will be able find out if the treatment would work over a shorter time course (months or years instead of decades). We will also gain important insight into the aging process, such as how a viral infection and emphysema may contribute to premature aging, and vice versa. Finally, this study may identify individuals who are at risk of developing emphysema with simple blood tests and lung function, so that a concerted effort can be directed to those who will be most likely in need of help.
Competitiondate
201109
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Man, S.F. Paul
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $374,683~ $0~